Harri Mustonen

4PUBLICATIONS
18CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 19, 2024
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma.

Matilda Roos-Mattila, Pauliina Kallio, Tamara J Luck

|Jan 16, 2022
Pancreatic cancer survival prediction via inflammatory serum markers.

Mira Lanki, Hanna Seppänen, Harri Mustonen

|Feb 22, 2018
Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor.

Tiina Vesterinen, Sanna Mononen, Kaisa Salmenkivi

|Dec 16, 2017
Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer.

Anna Nurmi, Harri Mustonen, Helka Parviainen

Pageof 1